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0022-2836 © 2007 Elsevier Ltd. Open acceThe transcription termination factor Rho of Escherichia coli is a RNA binding
protein which can translocate along the RNA and unwind the RNA:DNA
hybrid using the RNA-dependent ATPase activity. In order to investigate
the involvement of each of these functions in releasing RNA from the
elongation complex, we have isolated different termination defective
mutants of Rho by random mutagenesis, characterized them for their
different functions and established the structure–function correlations from
the available structural data of Rho. These mutations are located within the
two domains; the N-terminal RNA binding domain (G51V, G53V, and
Y80C) and in the C-terminal ATP binding domain (Y274D, P279S, P279L,
G324D, N340S, I382N) including the two important structural elements, the
Q-loop (P279S, P279L) and R-loop (G324D). Termination defects of the
mutants in primary RNA binding domain and Q-loop could not be restored
under any conditions that we tested and these were also defective for most
of the other functions of Rho. The termination defects of the mutants
(Y274D, G324D and N340S), which were mainly defective for secondary
RNA binding and likely defective for translocase activity, could be restored
under relaxed in vitro conditions. We also show that a mutation in a primary
RNA binding domain (Y80C) can cause a defect in ATP binding and induce
distinct conformational changes in the distal C-terminal domain, and these
allosteric effects are not predictable from the crystal structure. We conclude
that the interactions in the primary RNA binding domain and in the Q-loop
are mandatory for RNA release to occur and propose that the interactions in
the primary RNA binding modulate most of the other functions of Rho
allosterically. The rate of ATP hydrolysis regulates the processivity of
translocation along the RNA and is directly correlated with the efficiency of
RNA release. NusG improves the speed of RNA release and is not involved
in any other step.© 2007 Elsevier Ltd. Open access under CC BY license. Keywords: RNA polymerase; Rho; NusG; transcription termination;
mutagenesis*Corresponding authorIntroduction
Once the process of transcription is initiated, RNA
polymerase (RNAP) makes a stable elongation
complex with the DNA and the nascent RNA.1–3to the work.
polymerase; EC,
ugh efficiency.
ng author:
ss under CC BY license. Elongation complex (EC) only dissociates in
response to cis or trans termination signals. Distin-
guished by their mechanism and structural features,
there are two types of terminators in the Escherichia
coli genome. (a) Intrinsic terminators characterized
by a GC-rich inverted repeat followed by a oligo(dT)
stretch that induce RNA polymerase to disengage
RNA; and (b) the factor-dependent terminators,
which depend on an essential protein factor, called
Rho, for termination.4,5
Rho is a homo-hexameric RNA/DNA helicase or
translocase that dissociates RNA polymerase from
856 Functional Analyses of Rho MutantsDNA template and releases RNA. RNA-dependent
ATPase activity of Rho provides free energy for
these activities.6–8 The primary RNA binding site
(residues 22–116) can bind to a single-stranded DNA
molecule as well as a single-stranded RNAmolecule
and is responsible for recognizing the Rho utiliza-
tion (rut) site.9 Amino acid residues 179–183 form
the P-loop, a highly conserved region among the
RecA family of ATPases and is involved in ATP
binding and ATPase activity.10 The Q-loop and R-
loop have been defined as the secondary RNA
binding sites. The Q-loop is formed by an eight-
residue segment within 278–290 amino acid resi-
dues,10–13 while the R-loop spans between 322–326
amino acid residues.11,14,15
Rho-dependent termination involves a series of
sequential events. At first Rho binds to the C-rich
regions of the nascent RNA, called the rut site16–18
through its primary RNA binding domain. This
binding leads to the positioning of the RNA into the
secondary RNA binding domain, which in turn acti-
vates the ATPase activity. It utilizes the free energy
derived from the ATP hydrolysis for its translocase/
RNA–DNA helicase functions,6,7 which eventually
leads to the release of the RNA from the elongation
complex. It is commonly believed that the translo-
case/helicase activities of Rho is instrumental in
pulling out RNA from the elongating RNA poly-
merase.7 However, it is not well understood how
each of these events is related to the RNA release
process.
Here, we investigated the involvement of different
functions of Rho in releasing the RNA from the
elongation complex. We randomly mutagenized the
rho gene, isolated the termination defective mutants,
characterized each of them for their defects in other
functions and established a structure–function rela-
tionship of the effects of these mutations based on
the recent closed ring structure of Rho.19 This is in
contrast to earlier mutagenesis approaches which
were only restricted to identify the different func-
tional domains of Rho.13,14,20 We also established an
in vitro experimental set-up to measure the Rho-
mediated RNA release from a stalled EC, uncoupled
from the transcription elongation process. This set-
up enabled us to find the conditions under which
some of these mutants regained the efficiency of
RNA release and to understand the specific roles of
ATP and NusG in the process of Rho-dependent
termination. We concluded that the mutations in the
N-terminal primary RNA binding domain can exert
allosteric effects in the distal C-terminal domain,
and this domain may act as a “master switch” that
governs all the other functions of Rho. The primary
RNA binding domain and the Q-loop are the most
crucial structural elements for the RNA release func-
tion. Altered interactions in the secondary RNA
binding domain only reduce the rate of ATPase ac-
tivity which most likely slows down the transloca-
tion rate of Rho along the RNA. The rate of ATP
hydrolysis is directly correlated with the efficiency
of RNA release and involvement of NusG is restric-
ted only to the final step of RNA release from the EC.Results
Isolation of termination defective mutants of
Rho
We have randomly mutagenized the whole rho
gene and screened for mutants defective for termi-
nation at two Rho-dependent terminators (see
Materials and Methods). After screening about
100,000 colonies, we isolated nine unique mutations
in Rho which were severely defective for termina-
tion. These mutations are G51V, G53V, Y80C, Y274D,
P279S, P279L, G324D, N340S and I382N. G51V and
I382N mutations were independently isolated at
least six times. G51V and G53V were also isolated
earlier from a localized mutagenesis screen of the
primary RNA binding domain.20 Although the posi-
tions of the mutations indicate that the mutagenesis
was random, the classical polarity suppressor muta-
tions21 were not isolated by this method, the reason
of which is not clear to us. Termination defects
exhibited by these mutations on three Rho-depen-
dent terminators (defect for nutR/TR1 terminator is
described below) suggest that the defect is not
specific for a particular terminator. We also observed
that mutants other than G51V, Y80C and Y274D
caused a growth defect at 42 °C.
In vivo termination defects of the Rho mutants
To get a quantitative measure of the termination
defects of the Rho mutants, the ratio of β-galacto-
sidase made from a lacZ reporter fused to a Rho-
dependent terminator (Plac-H-19B nutR/TR1-lac-
ZYA) to that without the terminator (Plac-lacZYA)
was measured (read-through efficiency=%RT). This
Rho-dependent terminator is derived from the nutR-
cro region of a lambdoid phage H-19B22 and found
to behave similar to the nutR/TR1 of λ phage. These
reporter fusions were present as a single copy
prophage (see Materials and Methods and Table 6
for the strains). Different strains with these reporter
fusions were transformed with the plasmids carry-
ing the Rho mutants. The measurements were done
in the presence of either wild-type (WT) or B8 (rpoB,
Q513P) RNA polymerase in the chromosome and
either in the presence of a WT or chromosomal
deletion of Rho.
Compared to WT Rho, all the mutants showed a
significant defect in termination as evident from the
10 to 20-fold increase in terminator read-through
efficiency (Table 1, column 4). Even in the presence
of a WT copy of Rho, the read-through efficiency of
the mutants was significantly high (Table 1, column
7). This could be attributed to the multi-copy (copy
number of pCL1920 is ∼5)23 dominance of the
mutant Rho over WT Rho. The partial suppression
of the defects could also arise from the mixing of WT
and mutant protomers of Rho.
The kinetic coupling model of Rho-dependent ter-
mination predicts that a slow moving RNA poly-
merase can suppress the effect of defective Rho.24 So
Table 1. In vivo termination defects of the Rho mutants
Rho
alleles
WT RNAP β-Galactosidase
(arbitrary units)
B8 RNAP β-Galactosidase
(arbitrary units)
Δrho: kana WT rhob Δrho: kanc
+TR1 −TR1 %RT +TR1 −TR1 %RT +TR1 −TR1 %RT
WT 42±2 973±28 4.3 37±2 839±68 4.4 78.5±10 564±83 13.9
G51V 334±20 690±24 49.0 360±17 860.5±62 41.8 445±32 782±128 56.9
G53V 548.5±54 678±22 80.9 433±11 1055±45 41.0 458±48 636±96 72.1
Y80C 435±12 687±11 63.3 422±23 1072±46 39.3 645±60 850±180 75.8
Y274D 605.5±45 729±34 83.1 324±14 1183±44 27.4 435±45.5 623±115 69.8
P279S 362±8 677±25 53.4 308±6 870±10 35.4 345±42 633±122 54.5
P279L 686±39 1116±39 61.5 317±22 852±42 37.2 772±36 1304±84 59.2
G324D 636.5±24 1074±52 59.3 298±13 839±33 35.5 847±116 1127±18.5 75.1
N340S 732±45.5 1102±35 66.4 284±15.5 973±33 29.2 1272±93 1553±275 81.9
I382N 750±54 1158±24 64.8 290±11 1057±24 27.5 1050±33 1247±182 84.1
These above strains were transformedwith the plasmids bearing different WTand rhomutants. The ratio of β–galactosidase values in the
presence and absence of TR1 terminator gives the efficiency of terminator read-through (%RT). This Rho-dependent terminator is derived
from the nutR-cro region of a lambdoid phage H-19B and found to behave similar to the nutR/TR1 of λ phage. The averages of five to six
independent measurements are shown.
a Strains RS364 and RS391 with WT RNA polymerase and deletion of rho in the chromosome.
b Strains GJ3073 and RS445 with WT RNA polymerase and WT rho in the chromosome.
c Strains RS449 and RS450 with B8 RNA polymerase and deletion of rho in the chromosome.
857Functional Analyses of Rho Mutantswe wanted to know whether the defects of these
mutants could be suppressed by B8 (rpoB, Q513P), a
slow elongating RNA polymerase.25 Similar mea-
surements of termination read-through in the pre-
sence of B8 RNAP showed that defects of none of the
Rho mutants were suppressed by the “slow” RNAP
(Table 1, column 10), which is in contrast to earlier
observations of different Rho mutants being sup-
pressed by this RNAP.24,26 According to the kinetic
coupling model, slow RNAP will suppress only the
Rho mutants which are defective in translocation
along the RNA. Thus, either these mutants translo-
cate too slow to catch up B8 RNAP or these mutants
are defective in other steps of Rho-dependent ter-
mination. It is also noted that none of these mutants
were compatible with a fast moving RNAP, B2
(rpoB, H526Y). It was difficult to obtain transfor-
mants in the strain having B2 RNAP in the chromo-
some with all the plasmids bearing Rho mutants.
The defects of these Rho mutants might have
amplified in the presence of a fast moving RNAP
that caused this lethality. We also observed in-
creased read-through activity with the slow RNAP
(B8), which was unexpected (Table 1, column 10)
and the reason for this is not clear.
In vitro termination defects of the Rho mutants
In vitro transcription termination activity of the
Rho mutants was studied at the trp t'termina-
tor21,27,28 using purified WT and all the mutant
Rho proteins, except G53Vand P279L. We could not
purify G53V and P279L mutants because they
formed inclusion bodies under overexpression con-
ditions. A linear DNA template with the trp t' ter-
minator cloned downstream to the strong T7A1
promoter was used for transcription assays (see
Materials and Methods). In order to observe the
released RNA at the Rho-dependent terminationpoints, the templates were immobilized on strep-
tavidin-coated magnetic beads. In the assays, the
supernatant fractions contain the released RNA. The
WT Rho protein showed about 85% efficiency in
termination. Consistent with their in vivo pheno-
type, all the Rho mutants except I382N showed
significantly reduced termination efficiency (Figure
1(a) and (b)). The presence of NusG during the chase
improved the termination efficiency of Y274D,
G324D and N340S by about twofold (Figure 1(a)
and (b)). NusG, however, did not bring about early
termination in these mutants as observed for the WT
Rho (Figure 1(a)).
In order to validate the in vivo observation that
the termination defects of the Rho mutants could
not be suppressed by B8 RNAP, in vitro transcrip-
tions were also carried out with the B8 enzyme.
Consistent with the in vivo data (Table 1), the in
vitro assays (Figure 1(c)) also showed that B8
RNAP does not improve the termination efficiency
of the mutants significantly, except for Y274D. For
Y274D and G324D mutants, termination efficiency
was improved ∼1.5-to twofold in the presence of
NusG. These mutants (and N340S; see Figure 1(a)
and (b)) might have defects in the RNA release
step(s) from the EC, and NusG is likely to be
involved in this step during the Rho-dependent
termination process.
Location of the mutations on the crystal
structure of Rho and prediction of functional
defects
We mapped the positions of the mutations on the
recently reported hexameric closed ring structure of
Rho, which has both the primary and secondary
RNA binding sites occupied with nucleic acids19
(Figure 2(a) and (b)). In general, the mutations are
located within or close to the previously identified
Figure 1. In vitro termination defects of the mutant Rho proteins. (a) Autoradiogram of the in vitro transcription
termination by different Rho mutants both in the absence and presence of 200 nMNusG. Transcription was initiated from
T7A1 promoter. The DNA template was immobilized on magnetic beads. Rho-dependent RNA release starts from 100 nt
downstream of the transcription start site in the trp t' terminator region (as indicated). Major termination positions are
marked. Half of the supernatant is denoted as S (released RNA) and the rest of the reaction mixture containing both
supernatant and pellet is denoted as P (total RNA). RO denotes the run-off product. The read-through efficiency (RT) for
each case was calculated from the P lanes as: RT=[RO product]/[RO product + all the products≥100 nt]. (b) Measured RT
for each of the mutants is shown as bar diagrams usingWT RNA polymerase. Higher read through efficiencies of the Rho
mutants reflect their termination defect. (c) Read through efficiencies measured in the presence of B8 RNA polymerase.
858 Functional Analyses of Rho Mutantsimportant functional domains of Rho. Among them,
G51V, G53V and Y80C are in the primary RNA
binding domain (Figure 2(c)). Y274D, P279S and
P279L are in or close to the Q-loop (Figure 2(d)).
G324D and N340S are close to the secondary RNA
binding domain and G324D is in the R-loop (Figure
2(d)). The mutation I382N could not be located on
the structure as the C-terminal end of the closed ring
structure of Rho is not resolved. Interestingly, muta-
tions in these important structural elements of Rho
did not have a lethal phenotype.
It is revealed from the structure that amino acid
Y80 makes direct contact with the nucleic acid in
the primary RNA binding domain29 (Figure 2(c)). So
there is a high probability that Y80C change will
affect the primary RNA binding drastically. Amino
acids G51 and G53 also come within 12–14 Å of the
nucleic acid in the crystal structure and changes in
these amino acids can also affect the primary RNA
binding (see the distance calculations in Figure 2(e)).
The crystal structure revealed the binding of only
two nucleotides, whereas about ten nucleotides canbe occupied in the primary RNA binding site of a
monomer.30 Therefore it is likely that other amino
acids of this domain (including G51 and G53) will
take part in the primary RNA binding.31 Defect in
the primary RNA binding due to the change in these
three amino acids will subsequently affect the
secondary RNA binding and the RNA release
processes.
The amino acids G324 and N340 are situated close
to the RNA in the secondary RNA binding site
(Figure 2(d) and (e)). It is likely that G324, located
in the R-loop, will take part directly in the inter-
action with RNA. Therefore, it can be predicted that
changes in these two amino acids will cause a defect
in the secondary RNA binding and in the ATP hy-
drolysis activities. This may in turn affect the pro-
cessive translocation of Rho along the RNA, which
will lead to a termination defect.
P279S and P279L changes in the Q-loop can alter
the loop conformation by extending the length of the
preceding helix. The closed ring structure of Rho
revealed that the Q-loop is about 30 Å (Figure 2(e))
Figure 2. Location of the muta-
tions on the crystal structure of Rho.
In (a) and (b) the space-filled model
of hexameric closed ring structure of
Rho was generated from the avail-
able co-ordinates of the dimeric unit
of Rho (2HT119) and the Figures
were prepared using RASMOL.
Positions of the mutations are indi-
cated. The color codes are as fol-
lows. G51V, red; G53V, green; Y80C,
blue; Y274D, pink; P279S/P279L,
cyan; G324D, orange; N340S, violet.
The position of I382N is not re-
solved in this structure. In (a) the
view is from primary RNA binding
domain and that in (b) is from
secondary RNA binding domain.
(c) The primary RNA binding do-
main of Rho generated from the co-
ordinates of the structure of N-
terminal domain (2A8V29; left) and
closed ring (2HT1; right) structures.
The RNA oligonucleotide is shown
in yellow and locations of G51V,
G53V and Y80C are also shown as
spheres with the same color code
as in (a) and (b). (d) The secondary
RNA binding domain is shown in
the dimeric unit of the closed ring
structure with the RNA (in yellow)
bound at the interface of the two
monomers (chains are shown in
grey and black). P, Q and R loops
are shown in green and the locations
of Y274D, P279S/P279L, G324D
and N340S are also indicated as
spheres. Color codes for the muta-
tions are same as in (a) and (b). (e)
Distances of the positions of differ-
ent mutations from important func-
tional domains. The distances were
calculated using the RASMOL pro-
gram. For calculating the distances
from primary (1°) and secondary (2°) RNA binding domains, the nearest RNA residues were considered and that from the
P-loop, Cα atom of residue 184 was considered.
859Functional Analyses of Rho Mutantsaway from the nearest RNA residue in the second-
ary RNA binding site. In the closed ring structure
of Rho, the Q-loop forms a hairpin-like structure
from the disordered conformations observed in the
open ring structure.19 This alteration may be im-
portant for attaining the active conformation of Rho
and the change in the loop conformation due to the
mutations will affect its function. On the other hand
Y274, which is located just outside this loop, may
come on the pathway of the RNA passing through
the dimeric interface of two Rho protomers (Figure
2(d)). So Y274D may have similar defects as G324D
and N340S changes.
In order to test these predictions of the additional
defects of these mutants in different properties of
Rho, we assayed their efficiencies for primary and
secondary RNA binding as well as for their ATP
binding and hydrolysis activities.Primary RNA-binding properties of the Rho
mutants
There are two distinct types of polynucleotide
interaction sites in Rho.10,32 The primary RNA-
binding site, located in the N-terminal region,
recognizes both single-stranded DNA and RNA,
whereas the secondary binding site located at the
central hole of the oligomer, binds specifically to the
RNA. To investigate whether interactions in these
two sites were affected by these mutations, we
monitored the interactions specifically at the pri-
mary binding site by estimating the dissociation
constant (Kd) of each of the mutants for a 34-mer
DNA oligonucleotide, (dC)34. Occupancy of a DNA
oligomer only in the primary RNA binding site of
the Rho crystal15 and protection of primary RNA
binding domain by DNA oligomer in the protein
860 Functional Analyses of Rho Mutantsfootprinting studies,10 strongly suggest that DNA
can specifically bind to this site and not to the
secondary RNA binding site.
The dissociation constants (Kd) for oligo(dC)34
of different Rho mutants were measured by both gel
retardation and filter binding assays (Table 2,
column 2). The Kd value for WT Rho was ∼10 nM.
None of the mutants were defective for binding to
oligo(dC)34 except Y80C, which did not show
significant binding in both the gel retardation and
filter binding assays. In order to check whether this
defect is specific for a DNA oligo, we checked the
efficiency of binding of a radiolabeled RNA oligo,
rC10 to Y80C by UV cross-linking. This mutant
showed significantly reduced cross-linking effi-
ciency even at 20 μM of rC10 and did not show
any gel-shift compared toWT Rho (data not shown).
The binding defect of this mutation is consistent
with the fact that this amino acid directly stacks
against the base of the oligonucleotide29 (Figure
2(c)). Previously reported mutants in this region also
exhibited similar defects in primary RNA binding.33
G51V and P279S have about a threefold higher
affinity for oligo(dC)34 compared to WT. Therefore
the stability of the oligonucleotide-bound complexes
of these two mutants in the presence of both single-
stranded DNA and RNA as competitors was tested.
Rho complexed with end-labeled oligo(dC)34 was
challenged with increasing concentrations of either
unlabeled oligo(dC)34 (Figure 3, upper panel) or H-
19B croRNA having a rut site (Figure 3, lower panel).
It was observed that the G51V–oligo(dC)34 complex
was significantly resistant to both the competitors
compared to either WT or P279S complexes. This
unusually stable interaction at the primary RNA
binding site, which was not predicted from the
crystal structure, could affect the proper release ofTable 2. In vitro primary and secondary RNA binding prope
Rho mutants Kd
a (dC)34 (nM)
[poly(C)] at
half-maximal
ATPase activityb (μM)
ATPase
poly(C) R
ATP/min
WT 10±0.9 0.59±0.02 29
G51V 3±0.3 0.46±0.04 15
Y80C N3000 0.14±0.06 20
Y274D 12±1.4 0.43±0.02 14
P279S 3±0.1 0.78±0.03 33
G324D 10±2 0.72±0.05 19
N340S 11±2 0.51±0.09 23
I382N 12±3 0.30±0.02 20
a Kd values were average of those obtained from gel shift and fil
complexes were plotted against the concentration of Rho and the pl
dissociation constant. Concentration of oligo(dC)34 is expressed in ter
b Amount of radiolabeled inorganic phosphate release from [γ-32P]
Concentration of poly(C) corresponding to the half-maximal ATPase ac
concentration range of poly(C) was 0 to 5 μM, in terms of the nucleotide
the primary and secondary RNA binding sites. However, the measu
binding site, so the values obtained by this method will reflect bindin
c The initial rate of ATP hydrolysis in the presence of poly(C) as c
hydrolyzed ATP against time to the equation y=yo exp(-λt), where λ is
were considered for the calculations. Concentrations of ATP and poly
d Except forWT, G51Vand I382N, a significant amount of ATPase ac
expressed in terms of RNA ends. The concentration of ATP was 1 mM
e Except for WT and I382N, a significant amount of ATPase activit
expressed in terms of RNA ends. The concentration of ATP was 1 mMRNA from the primary RNA binding site of G51V
during the translocation process. It should be noted
that the position of G51 is about 14 Å away from the
nearest RNA residue (Figure 2(e)). Earlier it was
reported that a termination defective Rho mutant
G99V, in this same domain, also had a tighter (∼2.5-
fold higher compared to WT Rho) primary RNA
binding.21 Even though the amino acid P279 comes
within 16 Å of the RNA in the primary RNA binding
site (Figure 2(e)), it is difficult to envision from the
available structural data why a mutation in Q-loop
will increase the affinity for DNA in the primary
RNA binding site. The distortion of the loop
conformation due to this mutation might have an
allosteric effect in the nearby primary RNA binding
domain. In this context it is also to be mentioned that
a high affinity primary RNAbinding does not lead to
a formation of a “super Rho”.
Secondary RNA binding
Interaction of RNA in the secondary site is
mandatory to activate ATP hydrolysis.10,32 It has
been reported that due to theweak interactions at the
secondary RNA binding site, it is difficult to observe
the RNA binding at this site by using direct binding
assays.34,35 So we measured the concentrations of
poly(C), oligos rC10 (10-mer) and rC25 (25-mer)
required to elicit half-maximal ATPase activities in
the presence of excess ATP for estimating the binding
efficiency to this site. For the oligos, rC10 and rC25,
measurements were done in the presence of oligo
(dC)34 at the primary site, because short RNA oligos
(rC5–8) can elicit ATPase activity by binding to the
secondary site only in the presence of oligo(dC).14,36
None of the mutants showed a significant defect in
utilizing poly(C) as substrate (Table 2, column 3).rties of the Rho mutants
activity on
NAc (nmol of
per μg Rho)
[rC25] at half-maximal
ATPase activityd (μM)
[rC10] at half-maximal
ATPase activitye (μM)
.1±3.5 0.13±0.01 13.2±2.6
.5±0.2 15.45±1.75 N200
.4±0.2 N500 N200
.1±1.0 N500 N200
.1±2.3 N500 N200
.6±4.0 N500 N200
.6±1.4 N500 N200
.4±0.05 0.39±0.01 32.3±1.0
ter binding assays using end-labeled (dC)34. Fractions of bound
ot was fitted to a hyperbolic binding isotherm to determine the
ms of DNA ends. For Y80C there was no binding up to 3 μM.
ATP was plotted against the increasing concentration of poly(C).
tivity was determined by fitting the plot to a sigmoidal curve. The
s. The concentration of ATPwas 500 μM. Poly(C) will bind both to
rements are based on the activities solely in the secondary RNA
g defects, if any, in the secondary site.
ofactor was determined by fitting the plot of the amount of un-
the rate constant. The time-points in the linear region (up to 5min)
(C) were 1 mM and 20 μM, respectively.
tivity was not observed up to 500 μM rC25. Concentration of rC25 is
.
y was not observed up to 200 μM rC10. Concentration of rC10 is
.
Figure 3. Stability of Rho–oligo
C)34 complexes. Autoradiograms
f native PAGE showing the amount
f labeled oligo(dC)34 complexed
ith WT and different mutant Rho
roteins survived in the presence of
creasing concentrations of compe-
tors: upper panel, unlabeled oligo
C)34; lower panel, H-19B cro RNA.
he fraction of bound complex was
alculated as: [bound oligo]/[free
ligo+bound oligo]. The 5 nM
beled oligo(dC)34 was used to
rm complex with 50 nM of WT
nd mutant Rho proteins.
Table 3. ATP binding of the Rho mutants
Rho mutants Kd, app (μM)
WT 0.54±0.06
(11.7±2.2)
G51V 1.35±0.26
Y80C No cross-linking
(43.2±0.8)
Y274D 3.15±0.26
P279S 4.28±0.54
G324D 2.45±0.15
N340S 1.09±0.12
I382N 0.60±0.1
Apparent dissociation constant (Kd,app) of ATP was determined
by UV-cross-linking. The intensities of the cross-linked species
were plotted against increasing concentrations of [γ-32P]ATP and
Kd values were obtained from the hyperbolic fitting of the plots.
For Y80C, no cross-linking was observed up to 30 μM [γ-32P]ATP.
Km values of ATP for WTand Y80C are shown in parenthesis. The
concentration of WT and mutant Rho was 50 nM in hexamer.
861Functional Analyses of Rho MutantsOnly P279S and G324D showed slightly less affinity
compared to others. This was further supported by
the fact that the rates of ATP hydrolysis with poly(C)
were also not significantly different for the mutants
(Table 2, column 4). It was observed that a strong
substrate like poly(C) can mask the defects in
secondary site binding,12,37 so we used two shorter
RNA oligos, rC10 and rC25, to assess the binding
defects in the secondary site. All the mutants, except
I382N, failed to show significant amounts of ATP
hydrolysis even at a very high concentration of the
oligo, rC10 (Table 2, column 6). Even with the longer
oligo rC25, the affinity for G51V was only increased,
but still it showed ∼100-fold weaker affinity
compared to WT (Table 2, column 5). In general,
we concluded that except I382N, all the mutants
were defective in secondary RNA binding or they
had an extremely slow rate of ATP hydrolysis. This
defect should have contributed significantly in their
inability to terminate.
Most likely, the defect in binding of oligo (dC)34 to
the primary site of the Y80C mutant did not
stimulate the ATPase activity with the shorter oligos
at the secondary site. In case of G51V, the unusual
mode of binding of (dC)34 in the primary site, might
have failed to elicit the allosteric effect in the
secondary site. Earlier, the reported tight binding
mutant, G99V, also had a similar defect in binding to
oligo rC10.
21 Defects of G324D and N340S for
secondary RNA binding were predictable from
their locations close to this site. Although according
to the crystal structure19 (Figure 2(e)), amino acids
Y274 and P279 are more than 20 Å away from the
closest RNA residue in the secondary site, these data
and the previously obtained protein footprinting
results with Q-loop mutants12 strongly suggest that
this region of Rho also takes part in interactions with
the RNA in the secondary site.
ATP binding
We measured the apparent dissociation constant
(Kd,app) of ATP for WT and mutant Rho proteins
in the absence of the RNA cofactor by using the
UV-cross-linking technique. The apparent affinity of(d
o
o
w
p
in
ti
(d
T
c
o
la
fo
aATP for mutants Y274D, P279S and G324D was ob-
served to be reduced by five-to eightfold, whereas it
was comparable to WT for mutants N340S, G51V
and I382N (Table 3). Mutations in R and Q-loops
might have allosteric effects on the proximal P-loop,
the ATP binding site. Cross-talk between the R-loop
and P-loop has also been proposed from the closed
ring crystal structure of Rho.19 There was no sig-
nificant cross-linking of ATP for the Y80C mutant.
Cross-linking efficiency of the radiolabeled ATP
varied among different mutants to the extent that it
was negligible for Y80C. Absence of cross-linking
means that either the binding affinity for ATP is very
poor or some unusual conformational changes due
to the mutation has impaired the chemistry of cross-
linking. As Y80C can hydrolyze ATP in the presence
of poly(C) (Table 2) the mutant must have the ability
to bind ATP. Therefore, we measured the Km value
of ATP for this mutant using poly(C) as cofactor and
compared with the WT Rho (Table 3, data in
parentheses). Y80C, indeed showed about fourfold
increase in Km value, which indicated that the
binding of ATP has been affected due to this
mutation. It is of interest to note that a mutation in
the primary RNA binding domain can affect the
862 Functional Analyses of Rho Mutantsconformations in the ATP binding domain which is
located ∼40 Å away (Figure 2(e)).
Y80C change in the N-terminal causes
conformational changes in the distal C-terminal
domain
Besides impairing the primary RNA binding, the
Y80C mutation also caused significant defect in ATP
binding. This led us to hypothesize that this change
may cause conformational changes in the distalFigure 4. Conformational changes in the C-terminal do
acrylamide quenching of tryptophan fluorescence of WT and
calculated from these plots using the equation: (F0/F)350=1+
acrylamide. (b) Limited proteolysis of end-labeled WT and Y8
corresponding to the major cleavage products are indicated
intensity of the bands. These positions were identified from t
markers generated with CNBr and ArgC digestions of the sa
C-terminal are indicated to the left of the gel pictures. The thick
acids residues between 211 and 218. Individual amino acids
indicated by thin arrows. (c) Locations of the V8 sensitive res
structure of Rho. The red spheres are the V8 sensitive patch com
Also E106/108 is also indicated as red spheres in the N-termin
Y80C Rho is shown as a blue sphere.(∼40 Å) C-terminal domain allosterically. To test this
hypothesis, we probed the conformations of WTand
mutant Rho by limited proteolytic cleavages, fluor-
escence anisotropy and fluorescence quenching.
We monitored the surface accessibility of the
single tryptophan residue (W381), located ∼15 Å
away from the ATP-binding site, by the fluorescence
quenching technique using acrylamide as a neutral
quencher.38 This tryptophan residue emits a fluor-
escence signal at 350 nm upon excitation at 295 nm.
Quenching of this signal was plotted against themain of the Y80C mutant. (a) Stern–Volmer plots for
Y80C Rho proteins. The quenching constant (KSV) was
KSV[Q], where Q is the concentration of the quencher,
0C Rho proteins with V8 protease. Glutamic acid residues
by arrows. Thickness of the arrow corresponds to the
he calibration curve obtained from the molecular weight
me end-labeled Rho. The amino acid positions from N to
arrow corresponds to the sensitivity towards the glutamic
are not resolved. Position of 106/108 and 226 are also
idues are indicated on the dimeric unit of the closed ring
prising of glutamic acid residues at 211, 214, 215 and 218.
al domain. E226, which specifically became sensitive in the
863Functional Analyses of Rho Mutantsincreasing concentration of acrylamide to obtain the
quenching constant (Ksv) (Figure 4(a)). The value of
Ksv increases as the tryptophan becomes more
surface accessible. We observed that this tryptophan
in the Y80C mutant is more surface accessible
compared to the WT.
We used a fluorescent analogue of GTP, Tb-GTP,
which is a complex of terbium chloride and GTP,39,40
to see the local conformational flexibilities at the ATP
binding pocket. Here we assumed Tb-GTP will bind
to the same ATP binding site as GTP is also a good
substrate of Rho.41,42 We measured the anisotropy
(r) of the Tb-GTP moiety upon binding to the ATP
binding pocket. The anisotropy (r) of a fluorophore
gives the measure of the rotational freedom of the
species and reports the conformational flexibility of
the surroundings.39 A higher value of r means less
rotational freedom of the fluorescent probe. A lower
value of r for Tb-GTP bound to Y80C compared
to that obtained for WT Rho (Table 4) suggested
more conformational disorders in the ATP-binding
pocket.
In general, quenching constant and anisotropy
values did not change drastically because of the
Y80C mutation, which suggests that the conforma-
tional changes induced by the mutation in the C-
terminal domain are more subtle. To further cor-
roborate these data, we employed limited proteoly-
tic digestions of the WT and Y80C Rho proteins to
probe the conformational changes with V8 protease,
which cleaves preferably at glutamic acid residues.
We observed that a cluster of surface exposed
glutamic acid residues (Figure 4(b)) near the dimeric
interface of the C-terminal domain (Figure 4(c)) of
both the WT and Y80C mutants were very sensitive
to this protease. Interestingly, a new band corre-
sponding to Glu226, close to this cluster (Figure 4(c)
and (d)), was found to become sensitive to V8 di-
gestion, specifically in the Y80C mutant. This ob-
servation further supports the proposal that the
Y80Cmutation in the primary RNA binding domain
induces distinct but subtle conformational changes
in the distal C-terminal domain, which might have
affected the ATP binding domain and the surround-
ing regions.
RNA-release efficiency of the Rho mutants from
stalled elongation complex
The majority of the Rho mutants are defective in
secondary RNA binding, which might have affectedTable 4. Fluorescence anisotropy (r) values of Tb-GTP
Species Anisotropy (r)
Free Tb-GTP [150 μM: 50 μM] 0.096±.005
Tb-GTP+ 100 nM WT Rho 0.246±.007
Tb-GTP+ 150 nM Y80C Rho 0.183±.003
In all the experiments, Tb-GTP complexes were made by
incubating 150 μM Tb with 50 μM GTP. The majority of the Tb-
GTP species were in bound form in the presence of the indicated
amount of hexameric Rho. Anisotropies were measured at 25 °C.the processivity during translocation along the
nascent RNA and reduced the speed of transloca-
tion. We hypothesized that if their termination
defect is due to slow translocation only, these mu-
tants may be able to release RNA from the stalled
ECs if sufficient time is allowed. So we stalled the
EC on an immobilized template at a particular po-
sition within the trp t' terminator region (Figure 5(a))
using the lac repressor as a roadblock.43 The stalled
elongation complex remains transcriptionally active
and can restart transcription efficiently from this
position upon removal of the lac repressor43 (data
not shown). Under this condition the mutant Rho
proteins will eventually be able to “catch up” the
stalled EC if sufficient time is allowed and release
the RNA. Also in the stalled EC set-up, one can
monitor only the Rho-dependent RNA release
uncoupled from the transcription elongation process
and therefore the role of ATP and/or NusG on the
different steps of the RNA release can be studied
(see Figure 6).
To the stalled EC, WT or different mutant Rho
proteins were added and the released RNA in the
supernatant was monitored in the presence and
absence of NusG. Under this experimental condi-
tion, WT Rho released ∼70 to 80% of the RNA from
the stalled EC. Considering the non-specific rebind-
ing of the released RNA to the beads, these values
suggest an efficient release of RNA from the stalled
EC by Rho. In the absence of NusG, all the mutants
except I382N were still defective in releasing RNA
even from a stalled EC. However, in the presence of
NusG, a partial restoration in RNA release efficiency
was observed for Y274D, G324D and N340S (Figure
5(b) and (c)), which is similar to that observed in
continuous transcription assays (Figure 1(b), pre-
sence of NusG). This partial restoration of the RNA
release efficiency from the stalled EC in the presence
of NusG suggests that Y274D, G324D and N340S,
unlike WT Rho, are very much dependent on NusG
for interaction with the EC and possibly they are
defective in the step(s) involving the release of RNA
from the EC.
High concentration of ATP and the presence of
NusG restore the RNA release activity of the
mutants Y274D, G324D and N340S
In order to further identify the kinetic step(s)
defective for these Rho mutants we followed the
time-course of RNA release from the stalled EC in
the presence of different concentrations of ATP. We
varied the concentrations of ATP to change the
translocation rate. We preformed stalled EC, immo-
bilized on magnetic beads, removed all the NTPs by
extensive washing and WT or different mutant Rho
proteins were added in the presence of 0.02 mM,
0.1 mM (data not shown) and 1 mM ATP. The time-
course of RNA release in the supernatant was
followed for 30 min, both in the absence (Figure
6(a), (c) and (d)) and presence of NusG (Figure 6(b),
(e) and (f)). The rate (slope of the curve) and the
efficiency (maximum amount of released RNA) of
Figure 5. Rho-mediated RNA
release from the stalled elongation
complex. (a) Cartoon showing the
design of a stalled elongation com-
plex using lac repressor as a road-
block. In this set-up, the EC was
stalled at 161 position of the trp t'
terminator. Rho was added to the
reaction after the stalled complex is
formed and RNA release was mea-
sured from the supernatant. (b)
Autoradiogram showing the
amount of released RNA in the
supernatant by WT and different
Rho mutants both in the absence
and presence of 200 nM NusG from
the stalled EC. RB and RO denote
the positions of roadblocked pro-
duct and run-off product, respec-
tively. The meaning of S and P is
same as described for Figure 1. (c)
The RNA release efficiencies shown
by bar diagrams are calculated as:
[2S]/[S+P].
864 Functional Analyses of Rho MutantsRNA release remained the same for WT Rho at all
the concentrations of ATP tested. A modest incre-
ment of rate but not the efficiency of RNA release
was observed in the presence of NusG. RNA release
efficiency by the P279S mutant did not improve
significantly, even at 1 mM ATP and in the presence
of NusG. Under the same conditions, a modest
improvement in the RNA release efficiency was
observed for G51V and Y80C mutants, but it never
reached to the level of WT Rho. For Y274D, G324D
and N340S, the efficiency of RNA release improved
significantly when 1 mM ATP was present and
NusG was absent. For these mutants, both the ef-
ficiency and rate of RNA release was observed to
regain the WT Rho level in the presence of both
1 mM ATP and NusG.
Higher concentrations of ATP might have in-
creased the rate of ATP hydrolysis and as well as
improved the processivity of Y274D, G324D and
N340S Rho mutants, which in turn increased the
overall rate of translocation. This has enhanced the
chances of the Rho mutants to be in the vicinity of
the stalled EC. These mutants may also have defects
in the RNA release step, which most likely requires a
direct interaction with the EC. The presence of NusG
helped them to overcome this defect, which is
reflected in the faster RNA release (Figure 6(f)).Discussion
Here we report the isolation and characterization
of the termination defective mutants of Rho from
a random mutagenesis screen and attempt to
find the involvement and importance of different
functions of Rho in releasing RNA from the EC
in light of the recent crystal structure of Rho.19
Different properties of the mutants are summar-
ized in Table 5. All the termination defective
mutants (except I382N) were found to be located
in the previously identified functional domains,
such as in the primary RNA binding domain and
in the secondary RNA binding domain including
Q-loop and R-loops. The termination defect of the
mutants G51V, Y80C and P279S could not be
overcome under the most relaxed conditions that
have been tested, suggesting that the primary RNA
binding domain and Q-loop are the most crucial
elements for RNA release activity. These mutants
are also defective for most of the other functions
of Rho. The termination defects of the mutants
(Y274D, G324D and N340S), which are mainly
defective for secondary RNA binding and most
likely for the translocase activity, could be restored
under relaxed in vitro conditions. The functional
defects of most of the mutants correlate with their
Figure 6. ATP and NusG dependence of Rho-mediated RNA release from a stalled elongation complex.
Autoradiograms of the RNA release after 10 min of addition of different Rho mutants from the stalled EC (described
in Figure 5) in the presence of different concentrations of ATP, both in the absence (a) and presence (b) of 200 nM NusG.
(c)–(f) Curves showing the time courses of the RNA release upon addition of WT and different Rho mutants in the
presence of indicated concentrations of ATP. The presence or absence of NusG in the reactions is also indicated. The RNA
release efficiencies are calculated in the same way as described in Figure 5.
865Functional Analyses of Rho Mutantsspatial localization in the crystal structure. We also
show that mutations in the primary RNA binding
domain (Y80C) can affect functions and induce
conformational changes in the distal C-terminal
domain, which is not predictable from the structureof Rho. We did not observe any severe in vitro
defect in I382N, which is not consistent with its in
vivo phenotype. Probably a modest in vitro defect
can be amplified under more stringent in vivo
conditions.
Table 5. Summary of different properties of the
termination-defective Rho mutants
Mutants
1° RNA
binding
2° RNAa
binding
ATP
binding
Suppression of
termination defectb
G51V ++ +/− ++ No
Y80C − − +c No
Y274D + − + Yes
P279S ++ − + No
G324D + − + Yes
N340S + − ++ Yes
I382N + + +++ Not defective in vitro
WT + ++ +++ Not defective
All the activities of the mutants are expressed with respect to that
of WT Rho.
a Binding activities are for rC10 and rC25 templates. +/−
indicates ∼100 fold reduced binding on rC25 template.
b For the mutants Y274D, G324D and N340S the RNA release
efficiency from the stalled EC improves to the level of WT in the
presence of 1 mM ATP and NusG.
c For ATP binding of Y80C the Km value is considered.
866 Functional Analyses of Rho MutantsImportance of the polynucleotide interactions in
the primary RNA binding domain of Rho in modu-
lating other activities of Rho, apart from recognizing
the rut site, had been envisioned earlier.21,33 Here we
found that a specific mutation in position Y80,
which directly interacts with the RNA at the
primary site, intrinsically makes Rho defective for
ATP binding (Table 3), induces conformational
changes in the ATP-binding pocket (Figure 4(a)
and Table 4) and in the surrounding C-terminal
domain (Figure 4(b)). As the defect in ATP binding
and other conformational changes occurred in the
absence of RNA binding we propose that this
mutation by itself has induced a major allosteric
effect in the C-terminal domain, which is located far
away from primary RNA binding domain. On the
other hand, mutation at G51, located in the same
primary RNA binding domain, renders very stable
binding with the nucleic acids (Table 2 and Figure 3).
This leads to severe defects in the RNA release and
secondary RNA binding. This suggests that it is
important that Rho leaves the rut site once it starts
tracking the nascent RNA. Based on the properties
of these two point mutations in the primary RNA
binding domain we propose that this domain of Rho
not only works as an “eye” to find the rut site but
also exerts allosteric control over the downstream
interactions upon binding to RNA. Therefore, muta-
tions in this domain block the subsequent steps in
the process of RNA release. We have recently found
that Psu, an inhibitor of Rho, which inhibits Rho-
dependent termination by slowing down the rate of
ATP hydrolysis, does not interact with the Y80C
mutant.44 This lack of interaction between the Psu
and Y80C mutant might also arise due to confor-
mational changes in the ATP binding/hydrolysis
domain.
What is the role of Q-loop? The Q-loop is a
structural element, which is located at the entry
point of secondary RNA binding domain and pro-
trudes into the central hole of the Rho hexamer. A
comparison of the open and closed ring structures ofRho reveals that this loop undergoes major con-
formational changes upon ring closure19 and was
found to be protected in the Rho–poly(C) complex
from the hydroxyl radical cleavage.10 P279S and
earlier reported mutants in this loop12 are defective
in secondary RNA binding and in subsequent
activities like ATP hydrolysis and translocation.
Based on these results and the spatial location of
this loop in the Rho hexamer (Figure 4(c)), we
propose that this structural element works as a
rudder that guides the RNA into the dimeric
interface of the secondary RNA binding domain.
This proposal is consistent with the “RNA handoff
model”, where the Q-loop is proposed to be
involved in transferring RNA between the subunits
during translocation.19
It is known from the previous works that ATPase
or NTPase activity of Rho is required for transcrip-
tion termination45,46 and is believed that the free
energy generated from the hydrolysis is required for
the translocation of Rho along the RNA.47,48 Using a
roadblocked EC we have uncoupled the transcrip-
tion elongation from the Rho-dependent RNA
release from the EC, which enabled us for the first
time to observe a direct correlation between ATP
hydrolysis and RNA release by Rho from a stalled
EC. The RNA release efficiency and the rate of RNA
release improved at high concentration of ATP
for the three mutants (Y274D, G324D and N340S)
in the secondary RNA binding domain (Figure 6).
These results suggest that a higher rate of ATP hy-
drolysis improved their processivity and overall rate
of translocation and the free energy from the ATP
hydrolysis is used to bring them in the vicinity of
the EC. It is likely that the ATP hydrolysis helps Rho
to remain bound to the nascent RNA during the
“chase”, because intrinsically the interactions in the
secondary RNA binding domain are weak.
On the other hand, RNA release kinetics experi-
ments (Figure 6) suggest that NusG is involved only
in the RNA release step(s) once Rho reaches the
vicinity of the EC, which is consistent with role of
NusG that was proposed earlier.49 WT Rho on its
own is capable of releasing RNA, but the speed of
RNA release is increased in the presence of NusG.
Early termination that is usually observed in the
presence of NusG (Figure 1(a)) is the consequence of
this enhanced rate of RNA release. So the require-
ment of NusG becomes mandatory under in vivo
conditions where the RNA release has to be per-
formed within a small time window. The RNA
release step, in addition to their translocation defect,
must be severely compromised in case of the mu-
tants Y274D, G324D and N340S and therefore they
are highly dependent on NusG. The final RNA re-
lease step may involve a direct interaction of Rho
with the EC, so it is possible that the region of Rho
defined by these amino acids is involved in the
interaction with the EC.
Based on the properties of different termination
defective mutants of Rho and in the light of open
and closed ring hexameric structures complexed
with nucleic acids in primary and secondary RNA
867Functional Analyses of Rho Mutantsbinding domains we sum-up the sequential steps
that lead to the RNA release from the EC. (1) The
primary RNA binding domain binds RNA and
forms an open ring hexameric Rho. This interaction
also involves conformational changes in the C-
terminal domain. (2) RNA gets channeled into the
secondary RNA binding domain via the Q-loop and
the closed ring structure is formed. (3) This activates
ATP hydrolysis and onsets the translocation of Rho
along the mRNA, which brings Rho in the vicinity
of the EC. (4) Rho then releases RNA possibly by
pushing the EC or by pulling the RNA out of the EC
by its translocase activity. It is also possible that
Rho specifically interacts in the RNA exit channel
and exerts allosteric effects on the stability of the
EC. As NusG is only involved in increasing the rate
of RNA release at this step, it is possible that NusG
in the presence of Rho makes the EC more prone to
termination.
How important is Rho-dependent termination in
vivo? All the termination defective mutants of Rho
that we have isolated are viable. Among them, Y80C
is defective for most of the functions of Rho. Sur-
prisingly, these apparent severe defects did not cause
lethality to the cells. This raises the question, that
how important is the process of Rho-dependent ter-
mination when the cells are growing exponentially
and why Rho is essential to E. coli. We speculate that
due to the multi-functional nature of Rho, it may
very well have other essential function(s), which is
more important than transcription termination.Materials and Methods
Biochemicals and enzymes
NTPs, poly(C), [γ-32P]ATP (6000 Ci/mmol, 3000 Ci/
mmol and 30 Ci/mmol) and [α-32P]CTP (3000 Ci/mmol)
were purchased from Amersham. Antibiotics, IPTG,
lysozyme, DTT and BSA were from USB. Primers for
PCR, oligo(dC)34, rC10, rC25, galactose, Protein kinase A,
acrylamide and TbCl3 were obtained from Sigma.
Restriction endonucleases, polynucleotide kinase and T4
DNA ligase were from New England Biolabs. WT E. coli
RNA polymerase holoenzyme was purchased from
Epicenter Biotechnologies. Taq DNA polymerase was
from Roche. Staphyloccocal aureus V8 protease and Sub-
maxillary protease (Arg-C) were from Pierce. CNBr was
obtained from Fluka.Strain construction
Bacterial strains, plasmids and phages used in this
study are listed in Table 6. trpE9851(Oc)50 was moved by
P1 transduction from GJ3183 into GJ3192 and designated
as RS336. The Plac-H-19B nutR/TR1-lacZYA cassette
obtained from pK862822 was inserted as single copy at
the phage λ attachment site of strain RS336, resulting in
strain RS364. Similarly, single copy fusion without H-19B
TR1 rho-dependent terminator (Plac-lacZAY from pRS431)
was constructed and designated as RS391. rpoB825 and
rpoB225 genes were also moved into GJ3192 and named
as RS446 and RS451, respectively. Plac-H-19B nutR/TR1-lacZYA and Plac-lacZAY were inserted into RS446 in single
copy resulting in the strains RS449 and RS450, respec-
tively. Strain RS445 was constructed by single copy in-
sertion of Plac-lacZAY in GJ3161.
Random mutagenesis and screening of Rho mutants
The plasmid pHYD567 with the WT rho gene was
transformed into XL1-Red mutator strain (Stratagene).
The mutagenized plasmid library was isolated and elec-
troporated into the background strain RS336 with a
chromosomal deletion in the rho gene. In this strain, Rho
is supplied from a shelter plasmid carrying WT rho gene,
which has an IPTG dependent conditional replicon
(pHYD1201).
The transformants were plated on MacConkey agar
plates supplemented with 1% (w/v) galactose and ap-
propriate antibiotics. The strain was propagated in the
absence of IPTG to remove the shelter plasmid so that the
sole supply of Rho will be from the mutagenized plasmid
library. The galEP3 mutation in the strain confers Rho-
dependent transcriptional polarity on the downstream
genes, so that the cell is unable to utilize galactose to
satisfy its auxotrophy in the presence of a functional
Rho.51 Rho mutants can release polarity in such a strain
and can make the strain able to utilize galactose. gal+
transformants were picked, purified three times by
streaking in the same medium.
Mutant strains were streaked on a minimal anthranilate
plate to confirm the mutations. The trpE9851(Oc) mutation
confers Rho-dependent transcriptional polarity on the
downstream trpCDBA genes, so that the cell is unable to
utilize anthranilate in the presence of functional Rho. The
strain with WT Rho is incapable of growing on a minimal
anthranilate plate while Rho mutant strains can overcome
the polarity of the trpE9851(Oc) mutation. The putative
Rho mutant plasmids were isolated and re-transformed
into the background strain for ensuring the mutant pheno-
types. The full-length rho gene was sequenced from each
of these plasmids to identify the mutation and to ensure
that no other mutations were present in the gene.
Measurement of in vivo termination
The strains RS364 and RS391 were transformed with the
mutants and WT Rho plasmids to estimate the in vivo
termination efficiency at the H-19B TR1 rho-dependent
terminator. Similarly RS449 and RS450 were transformed
with the mutants and WT Rho plasmids to get the
activities with B8 RNAP. The strains GJ3073 and RS445
were used to get the β-galactosidase activities in the
presence of WT Rho. The measurements of β-galactosi-
dase activities were done in a microtiter plate using a
Spectramax plus plate reader following the published
procedure.52
Cloning and purification of wild-type and mutants of
Rho, NusG and B8 RNA polymerase
The WT and mutant rho genes were PCR amplified
using proof-reading DNA polymerase from pHYD567
and its derivatives (Table 6) and were cloned into the
XhoI/NdeI site of pET21b to introduce a His-tag at the
C-terminal end. All the mutant (except I382N) plasmids
were then transformed into the BL21(DE3) over expres-
sing strain. I382N was over expressed in salt-inducible
strain BL21SI (Invitrogen). After induction, His-tagged
Table 6. Bacterial strains, plasmids and phages used in this study
Strain/plasmid/phage Description Source or reference
A. Strains
GJ3192 MC4100 galEp3 Δrho::KanR with pHYD1201, AmpR 56
GJ3183 MC4100 galEp3 trpE9851(Oc) zci-506::Tn10 nusG-G146D rho-R221C 56
RS336 GJ3192, trpE9851(Oc) TetR This study
RS364 RS336, λRS45 lysogen carrying Plac – H-19B nutR-TR1-lacZYA This study
RS391 RS336, λRS88 lysogen carrying Plac –lacZYA This study
GJ3073 MC4100 galEp3, λRS45 lysogen carrying Plac – H-19B nutR-TR1-lacZYA Dr J. Gowrishankar
GJ3161 MC4100 galEp3 56
RS445 GJ3161, λRS88 lysogen carrying Plac –lacZYA This study
RpoB8 MG1655, rpoB8 TetR RifR 25
RS446 GJ3192, rpoB8 TetR RifR This study
RS449 RS 446, λRS45 lysogen carrying Plac – H-19B nutR-TR1-lacZYA This study
RS450 RS 446, λRS88 lysogen carrying Plac –lacZYA This study
RpoB2 MG1655, rpoB2 TetR RifR 25
RS451 GJ3192, rpoB2 TetR RifR This study
B. Plasmids
pHYD567 3.3 kb NsiI fragment carrying rho+ cloned from λ phage 556 of
Kohara library into PstI site of pCL1920 (pSC101; SpR, SmR)
56
pHYD1201 3.3 kb HindIII-SalI fragment carrying rho+ sub-cloned from pHYD567
into HindIII-SalI sites of pAM34 (pMB1; IPTG dependent replicon, AmpR)
56
pRS342 pHYD567-rho G51V, SpR, SmR This study
pRS387 pHYD567-rho G53V, SpR, SmR This study
pRS350 pHYD567-rho Y80C, SpR, SmR This study
pRS397 pHYD567-rho Y274D, SpR, SmR This study
pRS341 pHYD567-rho P279S, SpR, SmR This study
pRS347 pHYD567-rho P279L, SpR, SmR This study
pRS344 pHYD567-rho G324D, SpR, SmR This study
pRS346 pHYD567-rho N340S, SpR, SmR This study
pRS399 pHYD567-rho I382N, SpR, SmR This study
pK8628 pTL61T with Plac – H-19B nutR(TR1)-lacZAY fusion, Amp
R 22
pRS431 pTL61T with Plac – lacZAY by deletion of H-19B nutR-TR1between HindIII
and BamHI from PK8628, AmpR
This study
pRS106 pT7A1 cloned at EcoRI/HindIII sites upstream of trpt cloned at
HindIII/BamHI sites of pK8641, AmpR
44
pRS96 WT rho cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS378 rho G51V cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS381 rho Y80C cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS433 rho Y274D cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS377 rho P279S cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS379 rho G324D cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS380 rho N340S cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS432 rho I382N cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR This study
pRS119 WT nusG cloned at NdeI/XhoI site of pET21b, His-tag at C-terminal, AmpR 53
pRS236 lacI cloned at NdeI/XhoI site of pET21b, AmpR This study
pRS338 WT rho cloned at NdeI/XhoI site of pET21b, HMK tag and His-tag at
C-terminal, AmpR
This study
pRS602 rho Y80C cloned at NdeI/XhoI site of pET21b, HMK tag and His-tag at
C-terminal, AmpR
This study
C. Phages
λRS45 Dr J. Gowrishankar
λRS88 Dr Robert Weisberg
868 Functional Analyses of Rho MutantsWTand mutant Rho proteins were purified using Ni-NTA
beads (Qiagen) as per the manufacturer's protocol. The
proteins were eluted in the presence of 500 mM immida-
zole and further purified by passing through a heparin-
Sepharose column (Amersham). The expression levels for
all the mutants, except Y80C, were high and the majority
of the proteins were present in the soluble fraction. As the
expression level of Y80C was low, to avoid the contam-
ination from theWTRho expressed from chromosome, the
purification was done in the presence of 1 M NaCl. For all
the mutants the contamination from WT Rho protomers
was also checked by passing the mutant Rho proteins
through Ni-NTA columns in the presence of 1 M NaCl.
Due to the dissociation of the subunits at high salt, non-
His tagged WT protomers, if present, would be eluted inthe wash-fractions only. We estimated that the contamina-
tion from the WT protomer was less than 5% for all the
mutants. In all experiments concentrations of Rho is
expressed in terms of hexamer. Cloning and purification of
NusG has been described.53 B8 RNAP was purified
according to the published protocol.54
Solubility of mutant Rho proteins was reasonably good
andwe did not observe any aggregation over the period of
performing the experiments. Chemical cross-linking
showed that like WT Rho,55 all the mutant Rho proteins
remained as hexamer above the concentration of 1 μM
(data not shown). CD spectra of the different mutants
were similar to that of the WT Rho, indicating that the
overall structural integrity of the mutants was maintained
during the course of the experiments (data not shown).
869Functional Analyses of Rho MutantsThe composition of the different secondary structural
elements for WT and mutant Rho proteins are as follows.
α–Helix, 24–27%; β–sheet, 24–32%; turn, 13–17%; random
coil, 28–32%. So the differential activities and loss of
specific functions of the mutants in various assays were
not due to instability of the mutants or presence of inactive
fractions in the preparations.
Gel retardation and filter retention assays
RNA binding to the primary RNA-binding site of the
WT and mutant Rho proteins was measured by gel-
retardation and filter retention assays using an end-
labeled 34-mer oligo(dC). 10 nM of labeled oligo was
used for the binding assays in the transcription buffer
(25 mM Tris–HCl (pH 8.0), 5 mM MgCl2, 50 mM KCl,
1 mM DTT and 0.1 mg/ml of BSA) with the increasing
concentrations of the WT or the mutant Rho (0.1 nM to
300 nM). The reactions were performed at 37 °C for 5 min
before loading onto a 5% (w/v) native acrylamide gel.
Fraction of bound species was quantified by Image Quant
software of the phosphor-imager Typhoon 9200. Gel-shift
assays with labeled rC10 were also done in the same way.
For the filter retention assays, 5 μl of reaction mixtures (as
above) were spotted onto a nitrocellulose membrane in
duplicate and kept in a dot-blot apparatus (Bio-Rad). Each
spot was washed with 500 μl of transcription buffer under
vacuum. The fraction of bound oligo(dC)34 was estimated
from the ratio of the intensity of the washed (retained) and
unwashed (total) spots using Image-Quant software.
The dissociation constant values were calculated by
hyperbolic fitting of the binding isotherms. For the
competition assays, 10 nM oligo(dC)34 was allowed to
bind to 50 nM of WT or mutant Rho proteins for 5 min at
37 °C followed by adding 10 nM (1:1), 50 nM (1:5) and
100 nM (1:10) of either cold oligo(dC)34 or H-19B cro RNA
and incubating the reaction for further 5 min at 37 °C. The
amount of bound fraction that survived the competitor
was estimated from the band intensities.
ATPase assays
ATPase activity of the WTand mutant Rho proteins was
measured from the release of inorganic phosphate (Pi)
from ATP after separating on the polyethyleneimine TLC
sheets (Macherey-Nagel) using 0.75 MKH2PO4 (pH 3.5) as
the mobile phase. In all the ATPase assays the composition
of the reaction mixtures was 25 mM Tris–HCl (pH 8.0),
50 mM KCl and 5 mM MgCl2, 1 mM DTT and 0.1 mg/ml
of BSA. The reactions were stopped with 1.5 M formic acid
at the indicated time points. To determine the concentra-
tion of poly(C) required for half-maximal ATPase activity
(Table 2, column 3), 25 nM Rho was incubated with
different concentrations of poly(C) at 37 °C. Reaction was
initiated with 500 μMATP together with [γ-32P]ATP (6000
Ci/mmol) and was stopped after 15 min by formic acid.
Release of Pi was analyzed by exposing the TLC sheets to
a Phosphorimager screen for 5 min and subsequently by
scanning using Typhoon 9200 (Amersham) and quantified
by Image QuantTL software. The concentration of poly(C)
corresponding to half-maximal ATPase activity was
determined by fitting the plot of amount of Pi release
against concentration of poly(C) to a sigmoidal curve. To
determine the concentration of rC10 and rC25 correspond-
ing to half-maximal ATPase activity (Table 3, columns 4
and 5), the titrations were done in the presence of 1 μM
oligo(dC)34. The concentration of ATP was 1 mM. Other
conditions were similar to those described above.To calculate the Km values of ATP for WT and Y80C
mutant of Rho, in the same reaction mixture as described
above, 5 nM of Rho was incubated with 10 μM of poly(C)
at 30 °C for 10 min and ATP hydrolysis was initiated by
the addition of different concentration of ATP (10 μM –
100 μM). Aliquots were removed and mixed with 1.5 M
formic acid at various time points. The product formation
was linear in the time range (up to 5 min) that we used
for calculating the initial rate of reaction. The initial rates
of the reaction were determined by plotting the amount
of ATP hydrolyzed versus time using linear regression
method. Then the Km values were determined from the
double-reciprocal Lineweaver–Burk plots.
The rate of ATP hydrolysis in the presence of poly(C)
was measured in the same reaction mixture as described
above. The concentrations of Rho, ATP and poly(C) were
10 nM, 1 mM and 20 μM, respectively. Reactions were
performed at 30 °C and aliquots were removed at different
time points (at 30 s intervals up to 5 min) and mixed with
1.5 M formic acid.
Photo-affinity labeling of ATP and rC10 to Rho
To determine the apparent dissociation constant (Kd,app)
of ATP, UV cross-linking of labeled ATP was performed
with 50 nM Rho and varying concentrations of [γ-32P]ATP
(30 Ci/mmol) in a 10 μl reaction mixture containing
25 mM Tris–HCl (pH 8.0), 50 mM KCl, 5 mM MgCl2and
1 mMDTT. The samples were irradiated for 5 min at room
temperature in CL-1000 Ultraviolet cross-linker from UVP.
This method of determining the apparent dissociation
constant was used earlier.14,34 In a similar way the cross-
linking of labeled rC10 to WT and Y80C mutant of Rho
were performed. The samples were separated by SDS–
PAGE, followed by scanning the gels in the phosphor-
imager Typhoon 9200 and quantified by Image-Quant
software.
Fluorescence quenching and anisotropy
measurements
All the fluorescence experiments were performed in the
buffer containing 10 mM Tris–HCl (pH 7.0) and 100 mM
KCl at 25 °C in a Perkin Elmer LS 55 Luminescence
spectrometer. Changes in the tryptophan (W381) fluores-
cence at 350 nm of WT and Y80C Rho were monitored
upon exciting at 295 nm. Fluorescence quenching was
measured in the presence of different concentrations of a
neutral quencher, acrylamide. Normalized emission was
plotted against increasing concentrations of acrylamide
and the quenching constant (KSV) was obtained using
Stern-Volmer equation: (F0/F)350=1+ KSV[Q], where, F0 is
the initial fluorescence intensity andQ is the concentration
of acrylamide.
TbGTP (3:1; 150 μM of terbium chloride and 50 μM of
GTP) complex upon excitation at 295 nm gives rise to an
emission signal characterized by two emission peaks at
488 nm and 545 nm.39,40 We measured the fluorescence
anisotropies of this complex at 545 nm both in the absence
and presence of either WT or Y80C Rho proteins.
Limited proteolysis of Rho by V8 protease
The conformational changes induced by the Y80C mu-
tation were probed from the limited proteolysis pattern
generated by V8 protease. For the purpose of end-labeling
the protein, we used heart muscle protein kinase (HMK)
870 Functional Analyses of Rho Mutantstagged WT and Y80C Rho. The tag was introduced at the
C terminus by PCR amplification using appropriate
primers and was cloned in pET21b vector. The resultant
Rho proteins have both His and HMK-tags at the C-
terminal end. They were purified in a similar way as
described above and the termination assays showed that
these two tags did not interfere with the function of the
WT Rho. HMK-tagged Rho proteins were radiolabeled
with [γ-32P]ATP (3000 Ci/mmol) using protein kinase A.
The labeling reaction was done in buffer containing
20 mM Tris–HCl (pH 8.0), 150 mM NaCl, 10 mM MgCl2
and 10 μMATP. 30 μg of Rho were incubated with 60 units
of the kinase for 2 h at 21 °C. After labeling, 0.8 μM of
labeled Rho were incubated with 0.05 μg of V8 protease in
transcription buffer supplemented with 1 mM ATP for the
indicated time at 37 °C. The reactions were stopped by
adding 6X SDS-loading dye and were stored on ice.
Samples were heated to 95 °C for 3 min, prior to loading
onto a SDS–12.5%(w/v) PAGE. Gels were exposed over-
night to a phosphorimager screen and were scanned using
Phosphor-imager Typhoon 9200 and analyzed by Image-
Quant software. Molecular weight markers of end-labeled
Rho were generated by cyanogen bromide (CNBr) and
Sub-maxillary protease (Arg-C) mediated cleavages.
Methionine-specific cleavage reactions using CNBr con-
tained (pH adjusted to pH2 with 1 M HCl) 0.8 μM of
labeled Rho, 1 M CNBr and 0.4%(w/v) SDS in a 10 μl
reaction. Reaction mixtures for arginine specific cleavage
contained 0.8 μM of labeled Rho, 2 μg of Sub-maxillary
protease and 0.1%(w/v) SDS in a 10 μl reaction. Reactions
were terminated after 10 min at 37 °C by addition of 6X
SDS-loading dye followed by boiling.
Templates for in vitro transcription
Plasmid pRS106 containing trp t' terminator following a
strong T7A1 promoter was constructed by replacing the
H-19B nutR-triple terminator cassette from plasmid
pRS25.53 Linear DNA templates for in vitro transcription
were made by PCR amplification using the plasmid
pRS106. In order to immobilize the template on strepta-
vidin-coated magnetic beads, a biotinylated upstream
primer was used. The lac operator sequence was incorpo-
rated in a downstream primer to make the templates with
lac-operator at the downstream edge.43
In vitro Rho-dependent transcription termination
assay
In vitro Rho-dependent termination reactions were
performed in T buffer (25 mM Tris–HCl (pH 8.0), 5 mM
MgCl2, 50 mM KCl, 1 mM DTT and 0.1 mg/ml of BSA) at
37 °C. The template DNA was immobilized on the
streptavidin-coated magnetic beads (Promega), wherever
required, before starting the reaction. The reactions were
initiated with 10 nM DNA, 40 nM WT RNA polymerase,
175 μMApU, 5 μM each of GTP and ATP and 2.5 μMCTP
to make a 23-mer elongation complex (EC23). [α-
32P]CTP
(3000 Ci/mmol) was added to the reaction to label the
EC23. The complex was chased with 20 μM NTPs in the
presence of 10 μg/ml of rifampicin for 5 min at 37 °C.
50 nM WT Rho or Rho mutants and 200 nM NusG were
added to the chase solution as indicated. The reaction was
stopped by adding 20 μl of phenol after 5 min of
incubation at 37 °C and the released RNA was phenol
extracted. RNAwas fractionated in a 10% sequencing gel.
For the reactions with B8 RNAP, the enzyme concentration
was 100 nM and the EC was chased with 100 μM NTPs.RNA release from stalled elongation complex by WT
and Rho mutants
trp t' template with the lac operator sequence at position
161 was used to study RNA release from stalled elonga-
tion complex (RB) by WT and Rho mutants. In order to
make the stalled roadblocked complex on streptavidin
beads, lac repressor was added before addition of the
chasing solution. EC23 was made first and then was
chased with 20 μM NTPs and 10 μg/ml of rifampicin for
2 min to make the RB. This was followed by addition of
50 nM of either WTor mutant Rho proteins in the presence
or absence of 200 nMNusG. The reaction was incubated at
37 °C for 5 min and the supernatant was separated from
streptavidin beads on a magnetic stand to measure the
released RNA from the EC (Figure 5).
For the kinetics of RNA release from the RB, under
different concentrations of ATP both in the presence or
absence of NusG, RB was at first formed at position 161 of
the trp t' template as described above, except that EC23
was chased with 50 μM NTPs. The RB was then washed
extensively to remove the unincorporated NTPs and was
re-suspended in T buffer supplemented with different
concentrations of ATP (Figure 6). Following which 50 nM
WT Rho or Rho mutants with or without 200 nM NusG
were added to it. Half of the supernatant (S) was removed
at various time points and added to the equal volume of
RNA loading dye (Ambion). The rest of the reaction (half
of the supernatant+pellet; P) was phenol extracted and
mixed with the dye.Acknowledgements
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